Unbiased Analysis of Today's Healthcare Issues
As we start off 2026, I wanted to quickly look back at the research that I published in peer-reviewed journals last year. Here’s the list: Shafrin J, Jadhav K, Warren C, Quddus S, Zawadzki N, Yang D, Damon A, Spurrier K, Batt K, Wei D. Chronic myeloid leukemia treatment intolerance imposes additional resource and economic…
That is the title of a new paper out in Value in Health with co-authors Jaehong Kim, Jacob Fajnor, Kyi-Sin Than, Elizabeth S. Mearns , Stacey L. Kowal, Thomas Majda and Jakub P. Hlávka PhD. The abstract is below. Objectives To quantify how incorporating patient risk preferences and severity adjustments affect the value of a…
Check out my new publication with co-authors Suhail Thahir, Alexa Klimchak, Ivana Audhya, Lauren Sedita, and John Romley titled “Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy” in AJMC. The abstract is below. Objectives: To quantify the magnitude of an ISPOR novel value element, insurance value, as applied to new treatments for a rare,…
As we have turned the leaf to 2023, I figured I’d share the publications I had last year: Publications Forma F, Chiu K, Shafrin J, Boskovic DH, Veeranki SP. Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. Digital health. 2022 Mar;8:20552076221084472. Jackisch…
I provide the answer to this question in a recent paper in Current Medical Research & Opinion with co-authors Howard Thom, Edna Keeney, Daisy Gaunt, Lauren Zhao, Menaka Bhor, Avery Rizio, Lanetta Bronté-Hall and Nirmish Shah. The abstract is below. AimSickle cell disease (SCD) is a lifelong blood disorder affecting approximately 100,000 individuals in the…
That is the title of my recent blog post in Health Affairs with my co-author Meena Venkatachalam. The subtitle is “Expanding Value Assessment To Incorporate Health Inequality“. An excerpt is below: The brutal murder of George Floyd has brought renewed attention to systemic inequality that African Americans and other minorities face in the United States…
While many advancements have been made thus far in the progression toward value-based health care, there are persistent challenges in the measurement of value. In order to deliver value-based care, health care decision makers, eg, insurers and health system administrators, need value data at their fingertips—data that are relevant to their own context and reflect…
In a recent paper with Jeff Sullivan, Dana P. Goldman, and Thomas M. Gill in PLOS One, we try to answer this question. The paper’s abstract is below. Introduction Chronic diseases associated with aging, such as arthritis, frequently cause reduced mobility, pain and diminished quality of life. To date, research on the association between…
Value in Health has a Special Issue on Value Assessment Frameworks. The issue includes one of my papers (co-authored with Taylor T. Schwartz, Tony Okoro, John A. Romley) titled Patient Versus Physician Valuation of Durable Survival Gains: Implications for Value Framework Assessments. The abstract is below. Background: Previous research indicates that patients value therapies that provide…
Along with co-authors Amitabh Chandra and Ravinder Dhawan, please check out my most recent publication “Utility of Cancer Value Frameworks for Patients, Payers, and Physicians” in the latest issue of JAMA.